| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |